G6PC1 and fatty liver disease: Reduction of glucose-6-phosphatase activity and increase in adiponectin receptors, adiponectin, and AMPK phosphorylation have been associated with a decrease in fasting glucose, HbA1c, TG, cholesterol, and hepatic steatosis and increased insulin sensitivity and glucose tolerance.